BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27903658)

  • 1. Prognostic considerations of the new World Health Organization classification of lung adenocarcinoma.
    Borczuk AC
    Eur Respir Rev; 2016 Dec; 25(142):364-371. PubMed ID: 27903658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current readings: pathology, prognosis, and lung cancer.
    Suh JH
    Semin Thorac Cardiovasc Surg; 2013; 25(1):14-21. PubMed ID: 23800525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
    Warth A; Muley T; Meister M; Stenzinger A; Thomas M; Schirmacher P; Schnabel PA; Budczies J; Hoffmann H; Weichert W
    J Clin Oncol; 2012 May; 30(13):1438-46. PubMed ID: 22393100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.
    Takahashi M; Shigematsu Y; Ohta M; Tokumasu H; Matsukura T; Hirai T
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):54-9. PubMed ID: 24131786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.
    Travis WD; Asamura H; Bankier AA; Beasley MB; Detterbeck F; Flieder DB; Goo JM; MacMahon H; Naidich D; Nicholson AG; Powell CA; Prokop M; Rami-Porta R; Rusch V; van Schil P; Yatabe Y;
    J Thorac Oncol; 2016 Aug; 11(8):1204-1223. PubMed ID: 27107787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.
    Behera M; Owonikoko TK; Gal AA; Steuer CE; Kim S; Pillai RN; Khuri FR; Ramalingam SS; Sica GL
    Clin Lung Cancer; 2016 Sep; 17(5):e57-e64. PubMed ID: 27137345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Adenocarcinomas of Low Malignant Potential: Proposed Criteria to Expand the Spectrum Beyond Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.
    Yambayev I; Sullivan TB; Suzuki K; Zhao Q; Higgins SE; Yilmaz OH; Litle VR; Moreira P; Servais EL; Stock CT; Quadri SM; Williamson C; Rieger-Christ KM; Burks EJ
    Am J Surg Pathol; 2021 Apr; 45(4):567-576. PubMed ID: 33177339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.
    Kadota K; Villena-Vargas J; Yoshizawa A; Motoi N; Sima CS; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2014 Apr; 38(4):448-60. PubMed ID: 24472852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
    Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
    Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.
    Eguchi T; Kadota K; Park BJ; Travis WD; Jones DR; Adusumilli PS
    Semin Thorac Cardiovasc Surg; 2014; 26(3):210-22. PubMed ID: 25527015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma.
    Weichert W; Warth A
    Curr Opin Pulm Med; 2014 Jul; 20(4):309-16. PubMed ID: 24811831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The percentage of lepidic growth is an independent prognostic factor in invasive adenocarcinoma of the lung.
    Strand TE; Rostad H; Strøm EH; Hasleton P
    Diagn Pathol; 2015 Jul; 10():94. PubMed ID: 26159539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New T1 classification.
    Lin PMF; Hsin MK
    Gen Thorac Cardiovasc Surg; 2020 Jul; 68(7):665-671. PubMed ID: 31679135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the new IASLC/ATS/ERS proposed classification of adenocarcinoma based on lepidic pattern in patients with pathological stage IA pulmonary adenocarcinoma.
    Nakagiri T; Sawabata N; Morii E; Inoue M; Shintani Y; Funaki S; Okumura M
    Gen Thorac Cardiovasc Surg; 2014 Nov; 62(11):671-7. PubMed ID: 24890089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes.
    Mimae T; Miyata Y; Mimura T; Ito H; Nakayama H; Okumura S; Yoshimura M; Okada M
    Jpn J Clin Oncol; 2015 Aug; 45(8):767-73. PubMed ID: 26056324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society.
    Xu L; Tavora F; Battafarano R; Burke A
    Am J Surg Pathol; 2012 Feb; 36(2):273-82. PubMed ID: 22198010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society grading system has limited prognostic significance in advanced resected pulmonary adenocarcinoma.
    Westaway DD; Toon CW; Farzin M; Sioson L; Watson N; Brady PW; Marshman D; Mathur MM; Gill AJ
    Pathology; 2013 Oct; 45(6):553-8. PubMed ID: 24018816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.
    Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y
    Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Well-differentiated adenocarcinoma-bronchioloalveolar carcinoma-in situ adenocarcinoma: a conundrum.
    Weissferdt A; Kalhor N; Moran CA
    Adv Anat Pathol; 2013 Sep; 20(5):347-51. PubMed ID: 23939151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma in situ, minimally invasive adenocarcinoma, and invasive pulmonary adenocarcinoma--analysis of interobserver agreement, survival, radiographic characteristics, and gross pathology in 296 nodules.
    Boland JM; Froemming AT; Wampfler JA; Maldonado F; Peikert T; Hyland C; de Andrade M; Aubry MC; Yang P; Yi ES
    Hum Pathol; 2016 May; 51():41-50. PubMed ID: 27067781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.